Search

Displaying results 3851 - 3860 of 10000 in total
  1. Drug

    Mineral oil

    go.drugbank.com/drugs/DB11057
    ApprovedInvestigationalVet approved

    It is also used as a mild laxative for human or veterinary uses. … Mineral oil, or paraffin oil, is a mixture of higher alkanes from a mineral source, such as petroleum.

    Mixtures: AGAROL M (EMULSION), AGAROL CON SABOR A FRAMBUESAProducts: LIQUID PARAFFIN EMULSION 2.5 ml/5 ml, Mizon No.1 Kingsberry Cleansing Oi L
  2. Drug

    Trimethyltetradecylammonium

    go.drugbank.com/drugs/DB17342
    Experimental

    Synonyms: 1-tetradecanaminium, n,n,n-trimethyl-Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    VLX-1570

    go.drugbank.com/drugs/DB16030
    Investigational

    VLX-1570 is under investigation in clinical trial NCT02372240 (A Study of VLX1570 and Dexamethasone in Myeloma Patients).

    Categories: Heterocyclic Compounds, 1-RingSynonyms: (3E,5E)-3,5-Bis[(4-Fluoro-3-Nitrophenyl)Methylidene]-1-(Prop-2-Enoyl)Azepan-4-0Ne
  4. Drug

    Olitigaltin

    go.drugbank.com/drugs/DB12895
    Investigational

    Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.

    Synonyms: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-B-D-galactopyranosyl) sulfaneCategories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Sennosides

    go.drugbank.com/drugs/DB11365
    ApprovedInvestigational

    It typically begins working in minutes when given by rectum and within twelve hours when given by mouth[FDA Label]. It is a weaker laxative than bisacodyl or castor oil[A177092]. … Sennoside A, one of the sennosides present in the laxative medication, has recently proven effective in inhibiting the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV) reverse transcriptase

    Salts: Sennosides A and BMixtures: Laxatif De Sene Et Docusate De Sodium, EX-lax Gentle Strength
  6. Drug

    Peginterferon Alfacon-2

    go.drugbank.com/drugs/DB19335
    Investigational

    Peginterferon Alfacon-2 is under investigation in clinical trial NCT06544551 (Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection).

    Categories: peginterferon alfacon-2Synonyms: Interferon .alpha.1 (synthetic), n-terminal 20-kilodalton pegylated, Peginterferon Alfacon-2
  7. Drug

    Oxaliplatin

    go.drugbank.com/drugs/DB00526
    ApprovedInvestigational

    Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. … [A797] Although oxaliplatin has been investigated as a monotherapy, it is typically administered in combination with fluorouracil and leucovorin, known as the FOLFOX regimen, for the treatment of colorectal

    Categories: OCT2 Substrates with a Narrow Therapeutic IndexSynonyms: L-OHP, (SP-4-2-(1R-TRANS))-(1,2-CYCLOHEXANEDIAMINE-N,N')(ETHANEDIOATO(2-)-O,O')PLATINUM
  8. Drug

    SARS-CoV-2 Sclamp

    go.drugbank.com/drugs/DB15849
    Investigational

    Preclinical trials showed the vaccine candidate produced high levels of neutralizing antibodies, and induced a strong T-cell response. … As of July 13, 2020, the candidate is being tested for safety and immunogenicity in Phase 1 clinical trials in Queensland (ACTRN12620000674932).

    Synonyms: UQ-1-SARS-CoV-2-Sclamp, SARS-CoV-2 Sclamp adjuvanted vaccine
  9. Drug

    SC 41930

    go.drugbank.com/drugs/DB17101
    Experimental

    Synonyms: (+/-)-7-(3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy)-3,4-dihydro-8-propyl-2h-1-benzopyran-2-carboxylic acid, 2h-1-benzopyran-2-carboxylic acid, 7-(3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy)-3,4-dihydro-8-propyl-Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  10. Drug

    BNC-210

    go.drugbank.com/drugs/DB19048
    Investigational

    BNC-210 is under investigation in clinical trial NCT04951076 (A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-traumatic Stress Disorder (PTSD)).

    Synonyms: 1,8-NAPHTHYRIDIN-4(1H)-ONE, 6-((2,3-DIHYDRO-1H-INDEN-2-YL)AMINO)-1-ETHYL-3-(4-MORPHOLINYLCARBONYL)-, 6-((2,3-dihydro-1h-inden-2-yl)amino)-1-ethyl-3-(4-morpholinylcarbonyl)-1,8-naphthyridin-4(1h)-one